The Global Kidney Function Tests Market size is expected to reach $1.4 billion by 2027, rising at a market growth of 7.6% CAGR during the forecast period. There are various categories of kidney function tests or renal tests such as concentration and dilution tests, clearance tests (gives an evaluation of the filtration rate of the glomeruli, the principal filtering structures of the kidneys, complete renal blood flow), and visual & physical assessment of the urine. In addition to it, there are some other tests also that include identification of the concentration of various substances in the urine, mainly sodium, glucose, phosphate, potassium, and amino acids to assist in identifying possible non-function of the particular kidney functions commonly involved with their reabsorption.
The growth of the market would be boosted by many factors including high investments by the leading market players, a growing number of R&D activities, high occurrences of kidney diseases, and an increasing number of supportive government initiatives. Kidney function tests refer to simple laboratory tests which are utilized for evaluating and identifying functions of the kidney. The demand for kidney tests has been fueled by the growing cases of Chronic Kidney Disease (CKD) and Acute Kidney Injury (AKI) owing to the increasing occurrences of diabetes and hypertension.
As per the study conducted by the National Kidney Foundation, people who needed hospitalization due to the COVID-19 are at a considerable risk of getting AKI. The study revealed that COVID-19 patients were twice vulnerable to develop AKI in comparison to non-COVID-19 patients. Health regulatory bodies suggested that COVID-19 patients who had an AKI should get regular testing as their chances of developing CKD are more as compared to others. These aspects are likely to open growth avenues for the global kidney function tests market during the forecast period.
Based on Product, the market is segmented into Clearance Test, Blood Tests, Urine Tests, Dilution & Concentration Tests, and Others. The clearance tests segment obtained a substantial revenue share of the global kidney function tests market in 2020 and would emerge as the dominating segment during the forecast period. Clearance tests are considered as the gold standard for observation and assessment of glomerular filtration rate.
Based on End Use, the market is segmented into Hospitals, Diagnostic Laboratories, Research Laboratories and Institutes and others. The diagnostic laboratories segment would garner a higher market share during the forecast years as these labs are affordable, can perform many tests, and offer precise results. The research laboratories and institutes segment would record the highest growth rate throughout the forecast period due to the growing number of R&D activities in regions like North America and Europe.
| Report Attribute | Details |
|---|---|
| Market size value in 2020 | USD 820.8 Million |
| Market size forecast in 2027 | USD 1.4 Billion |
| Base Year | 2020 |
| Historical Period | 2017 to 2019 |
| Forecast Period | 2021 to 2027 |
| Revenue Growth Rate | CAGR of 7.6% from 2021 to 2027 |
| Number of Pages | 171 |
| Number of Tables | 288 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling |
| Segments covered | Product, End Use, Region |
| Country scope | US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria |
| Growth Drivers |
|
| Restraints |
|
Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. On the basis of region, North America appeared as the dominating region in the global kidney function tests in 2020 by obtaining the maximum revenue share of the market. The region would maintain a similar trend even during the forecast period. This is credited to the developed healthcare framework, growing awareness about CKD, and the supportive reimbursement policies and government initiatives.
Free Valuable Insights: Global Kidney Function Tests Market size to reach USD 1.4 Billion by 2027
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens AG, Randox Laboratories Limited, Quest Diagnostics, Incorporated, Laboratory Corporation of America holdings, Sysmex Corporation, ACON Laboratories, Inc., and Nova Biomedical Corporation.
By Product
By End Use
By Geography
The global kidney function tests market size is expected to reach $1.4 billion by 2027.
The increasing number of chronic diseases across the world are driving the market in coming years, however, huge process of diagnostic procedures have limited the growth of the market.
Abbott Laboratories, Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens AG, Randox Laboratories Limited, Quest Diagnostics, Incorporated, Laboratory Corporation of America holdings, Sysmex Corporation, ACON Laboratories, Inc., and Nova Biomedical Corporation.
The expected CAGR of the kidney function tests market is 7.6% from 2021 to 2027.
The hospitals segment gained the maximum revenue share in 2020 and would remain the leading revenue generating segment even during the forecast years.
The North America market dominated the global kidney function tests Market in Region 2020.
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 